Screeningul de cancer nu duce decat la marirea numarului de bolnavi

Cu cat primeste cineva mai devreme diagnoza de cancer, cu atat mult timp va fi bolnav.
Datorita screeningului aplicat in masa de 20 de ani toti mai multi oameni devini "bolnavi de cancer" si sunt tratati prin operatii, radiatii si toxine chimice, cei mai multi insa fara succes. Rata cancerului cat nu a scazut prin aceste masuri.
Asa cum arata publicatia medicala de mai jos screeningul de cancer la prostata sau la san nu duce deloc la o sansa mai mare de vindecare si nici la scadera cancerului ci este o metodta care duce numai la un numar mai mare de bolnavi si implicit
la spitale pline si vanzare crescuta de medicamente. De socul psihic la aflarea daignozei de cancer nu mai vorbim caci acesti oameni sunt convinsi din ziua diagnozei (de mult ori si gresita) ca sufera de o boara letala si traiesc incepand cu aceea zi cu frica "in san" ceea ce in sine este o cauza care duce la boala si deces.

Screeing pentru cancer nu este deloc in folosul pacientilor si in folosul industriei farmaceutice si medicale.

Rethinking Screening for Breast Cancer and Prostate Cancer
Sursa: http://jama.ama-assn.org/cgi/content/short/302/15/1685
Laura Esserman, MD, MBA; Yiwey Shieh, AB; Ian Thompson, MD
JAMA. 2009;302(15):1685-1692.

After 20 years of screening for breast and prostate cancer, several observations can be made. First, the incidence of these cancers increased after the introduction of screening but has never returned to prescreening levels. Second, the increase in the relative fraction of early stage cancers has increased. Third, the incidence of regional cancers has not decreased at a commensurate rate. One possible explanation is that screening may be increasing the burden of low-risk cancers without significantly reducing the burden of more aggressively growing cancers and therefore not resulting in the anticipated reduction in cancer mortality. To reduce morbidity and mortality from prostate cancer and breast cancer, new approaches for screening, early detection, and prevention for both diseases should be considered.